East Texas Medical Center Cancer Institute Tyler Hem/Onc (3) — Tyler, Texas

East Texas Medical Center Cancer Institute Tyler Hem/Onc (3) is a clinical research site located in Tyler, Texas, United States 75701.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

East Texas Medical Center Cancer Institute Tyler Hem/Onc (3) has participated in 1 clinical trials.

Therapeutic areas: First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tyler

Browse all research sites in Texas · View every site in Tyler

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for East Texas Medical Center Cancer Institute Tyler Hem/Onc (3)?

East Texas Medical Center Cancer Institute Tyler Hem/Onc (3) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has East Texas Medical Center Cancer Institute Tyler Hem/Onc (3) conducted?

East Texas Medical Center Cancer Institute Tyler Hem/Onc (3) has 1 clinical trials on record. Their work covers First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis.

Is East Texas Medical Center Cancer Institute Tyler Hem/Onc (3) accredited by Crixeo Clinical Trials?

East Texas Medical Center Cancer Institute Tyler Hem/Onc (3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about East Texas Medical Center Cancer Institute Tyler Hem/Onc (3)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.